Multicenter pilot study demonstrates reduced trauma-related sexual symptoms in an underserved population, indicating favorable safety and preliminary therapeutic value.
< .05), while reported side effects remained minimal. TrusT appears to be a safe and well-tolerated intervention with encouraging preliminary effects on trauma-related sexual symptoms in a clinically underserved population. Further research, including randomized controlled trials, is necessary to confirm efficacy and inform integration into trauma-focused treatment frameworks.
No takes yet. Share an insight, caveat, or question.
Gleixner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: